XML 70 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Note 13 - Stock Based Compensation (Tables)
12 Months Ended
Jul. 02, 2023
Notes Tables  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
  

Years Ended

 
  

July 2, 2023

  

July 3, 2022

  

June 27, 2021

 
  

(in thousands)

 
             

Stock options

 $2,536  $(41

)

 $36 

Restricted stock awards

  5,798   7,988   10,799 

Total

  8,334   7,947   10,835 

Deferred income tax benefit

  2,042   1,943   2,673 

Stock-based compensation expense, net

 $6,292  $6,004  $8,162 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Years Ended

 
  

July 2, 2023

  

July 3, 2022

  

June 27, 2021

 
  

(in thousands)

 
             

Marketing and sales

 $3,818  $3,414  $4,943 

Technology and development

  698   319   652 

General and administrative

  3,818   4,214   5,240 

Total

 $8,334  $7,947  $10,835 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Years ended

 
  

July 2, 2023

  

July 3, 2022 (1)

  

June 27, 2021 (1)

 
             

Weighted average fair value of options granted

 $5.13   n/a   n/a 

Expected volatility

  52%  n/a   n/a 

Expected life (in years)

  7.5   n/a   n/a 

Risk-free interest rate

  4.3%  n/a   n/a 

Expected dividend yield

 

0/0%

   n/a   n/a 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Options

  

Weighted
Average
Exercise
Price

  

Weighted
Average
Remaining

Contractual
Term

  

Aggregate
Intrinsic
Value

 
          

(in years)

  

(in

thousands)

 

Outstanding beginning of period

  -  $-         

Granted

  2,346,416  $8.59         

Exercised

  -  $-         

Forfeited/Expired

  (60,808

)

 $8.59         

Outstanding end of period

  2,285,608  $8.59   9.35  $- 
                 

Exercisable at July 2, 2023

  -  $-   -  $- 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]
    

Options Outstanding

  

Options Exercisable

 

Exercise Price

  

Options

Outstanding

  

Weighted

Average

Remaining Contractual Life (years)

  

Weighted

Average

Exercise

Price

  

Options

Exercisable

  

Weighted

Average

Exercise

Price

 
                       
$8.59   2,285,608   9.4  $8.59   -  $- 
     2,285,608   9.4  $8.59   -  $- 
Schedule of Nonvested Share Activity [Table Text Block]
  

Shares

  

Weighted

Average

Grant Date

Fair Value

 
         

Non-vested – beginning of period

  929,709  $21.82 

Granted

  757,754  $8.48 

Vested

  (385,965

)

 $18.10 

Forfeited

  (69,864

)

 $17.77 

Non-vested - end of period

  1,231,634  $15.01